Pro108Ser mutation of SARS-CoV-2 3CL^pro reduces the enzyme activity and ameliorates the clinical severity of COVID-19

Medicine & Life Sciences

• SARS Virus 100%
• Chymases 96%
• Mutation 37%
• Enzymes 37%
• Protease Inhibitors 20%
• semen liquefaction factor 17%
• Hydrogen Deuterium Exchange-Mass Spectrometry 16%
• Cause of Death 7%
• Oxygen 6%
• Amino Acids 6%
• Placebos 6%
• Randomized Controlled Trials 6%
• Viruses 6%
• Clinical Trials 6%